Cargando…
Nano-based delivery of RNAi in cancer therapy
BACKGROUND: RNA interference (RNAi), a newly developed method in which RNA molecules inhibit gene expression, has recently received considerable research attention. In the development of RNAi-based therapies, nanoparticles, which have distinctive size effects along with facile modification strategie...
Autores principales: | Xin, Yong, Huang, Min, Guo, Wen Wen, Huang, Qian, Zhang, Long zhen, Jiang, Guan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534073/ https://www.ncbi.nlm.nih.gov/pubmed/28754120 http://dx.doi.org/10.1186/s12943-017-0683-y |
Ejemplares similares
-
Nanoparticles as Drug Delivery Systems of RNAi in Cancer Therapy
por: Li, Diedie, et al.
Publicado: (2021) -
Oral delivery of RNAi for cancer therapy
por: Afrin, Humayra, et al.
Publicado: (2023) -
Delivery of RNAi-Based Oligonucleotides by Electropermeabilization
por: Chabot, Sophie, et al.
Publicado: (2013) -
RNAi-Based Approaches for Pancreatic Cancer Therapy
por: Kim, Min Ju, et al.
Publicado: (2021) -
Protein-based vehicles for biomimetic RNAi delivery
por: Pottash, Alex Eli, et al.
Publicado: (2019)